RWA Wealth Partners’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,915
Closed -$470K 278
2022
Q3
$470K Hold
1,915
0.03% 163
2022
Q2
$474K Buy
1,915
+20
+1% +$5.4K 0.03% 160
2022
Q1
$628K Hold
1,895
0.04% 150
2021
Q4
$681K Hold
1,895
0.05% 154
2021
Q3
$617K Hold
1,895
0.05% 152
2021
Q2
$591K Hold
1,895
0.04% 154
2021
Q1
$604K Sell
1,895
-125
-6% -$40K 0.05% 152
2020
Q4
$655K Hold
2,020
0.06% 146
2020
Q3
$560K Hold
2,020
0.06% 144
2020
Q2
$488K Sell
2,020
-575
-22% -$115K 0.06% 146
2020
Q1
$377K Hold
2,595
0.05% 147
2019
Q4
$443K Hold
2,595
0.04% 171
2019
Q3
$462K Hold
2,595
0.05% 166
2019
Q2
$676K Hold
2,595
0.07% 146
2019
Q1
$741K Hold
2,595
0.08% 134
2018
Q4
$843K Hold
2,595
0.11% 120
2018
Q3
$1.17M Hold
2,595
0.13% 110
2018
Q2
$1.06M Buy
+2,595
New +$940K 0.12% 119

Other funds holding ABMD

RWA Wealth Partners's ABMD Position: Q4 2022 in Review

RWA Wealth Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,915 shares — an estimated $470K sold.

RWA Wealth Partners first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $1.17M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • RWA Wealth Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • RWA Wealth Partners sold 1,915 Abiomed Inc shares in Q4 2022, an estimated $470K.
  • RWA Wealth Partners first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • RWA Wealth Partners's Abiomed Inc position peaked at $1.17M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on RWA Wealth Partners's 13F filing for Q4 2022, filed 19 Jan 2023.